Your session is about to expire
← Back to Search
Behavioural Intervention
PEAR-008 for Opioid Use Disorder
N/A
Waitlist Available
Research Sponsored by Pear Therapeutics, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Provide informed consent prior to any study specific assessments being performed
Between 18 and 60 years old, inclusively
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 1, week 2, week 3, week 4, week 5, week 6, week 7, week 8 (end of treatment), week 12 (follow-up)
Awards & highlights
Study Summary
This trial will help researchers understand if a game-based mobile app can help people with opioid use disorder.
Eligible Conditions
- Opioid Use Disorder
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ week 1, week 2, week 3, week 4, week 5, week 6, week 7, week 8 (end of treatment), week 12 (follow-up)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 1, week 2, week 3, week 4, week 5, week 6, week 7, week 8 (end of treatment), week 12 (follow-up)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Evaluate Participant Engagement Data
Secondary outcome measures
Assess Coronavirus Disease (COVID-19) Impact
Assess Coronavirus Disease (COVID-19) Impact on Stress
Anxiety
+8 moreOther outcome measures
Change in Skill Acquisition
Evaluate Engagement and Efficacy Relationship
Medication Adherence Rates
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: PEAR-008Experimental Treatment1 Intervention
Investigational Digital Therapeutic
Group II: reSET-OActive Control1 Intervention
Prescription Digital therapeutic
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PEAR-008
2021
N/A
~60
Find a Location
Who is running the clinical trial?
National Institute on Drug Abuse (NIDA)NIH
2,447 Previous Clinical Trials
2,594,014 Total Patients Enrolled
Pear Therapeutics, Inc.Lead Sponsor
5 Previous Clinical Trials
1,865 Total Patients Enrolled
Addiction Research and Education Foundation (AREF)UNKNOWN
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger